Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Essen Biotech
M.D. Anderson Cancer Center
City of Hope Medical Center
Curacell Holding AB
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Valo Therapeutics Oy
TCR2 Therapeutics
University of Pittsburgh
M.D. Anderson Cancer Center
University of Pittsburgh
ImmunityBio, Inc.
ImmunityBio, Inc.
Acepodia Biotech, Inc.
Essen Biotech
BioEclipse Therapeutics
Fate Therapeutics
Fate Therapeutics
BGI, China
Ludwig Institute for Cancer Research
Incyte Corporation
Karolinska University Hospital
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Haukeland University Hospital
M.D. Anderson Cancer Center
HaEmek Medical Center, Israel
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
Mayo Clinic
BGI, China
Rutgers, The State University of New Jersey
National Cancer Institute (NCI)
Immatics Biotechnologies GmbH
Cancer Research UK